Madrigal Pharmaceuticals to Release Third-Quarter 2024 Financial Results and Host Webcast on October 31, 2024
Madrigal Pharmaceuticals (Nasdaq: MDGL) has announced it will release its third-quarter 2024 financial results on Thursday, October 31, 2024, before the U.S. financial markets open. Following this, the company's management will host a live webcast at 8 a.m. Eastern Time to review Madrigal's financial and operating results.
Interested parties can access the webcast through the Investor Relations section of Madrigal Pharmaceuticals' website. To ensure a timely connection, participants are advised to register at least 15 minutes before the scheduled start. The webcast will remain available for approximately two hours after the live event concludes.
Madrigal Pharmaceuticals (Nasdaq: MDGL) ha annunciato che rilascerà i suoi risultati finanziari del terzo trimestre 2024 giovedì 31 ottobre 2024, prima dell'apertura dei mercati finanziari statunitensi. Successivamente, il management dell'azienda ospiterà un webcast dal vivo alle 8:00 ora orientale per rivedere i risultati finanziari e operativi di Madrigal.
Le parti interessate possono accedere al webcast attraverso la sezione Relazioni con gli Investitori del sito web di Madrigal Pharmaceuticals. Per garantire una connessione tempestiva, si consiglia ai partecipanti di registrarsi almeno 15 minuti prima dell'inizio programmato. Il webcast resterà disponibile per circa due ore dopo la conclusione dell'evento dal vivo.
Madrigal Pharmaceuticals (Nasdaq: MDGL) ha anunciado que publicará sus resultados financieros del tercer trimestre de 2024 el jueves 31 de octubre de 2024, antes de la apertura de los mercados financieros en EE. UU. Después de esto, la dirección de la empresa llevará a cabo un webcast en vivo a las 8 a.m., hora del Este para revisar los resultados financieros y operativos de Madrigal.
Las partes interesadas pueden acceder al webcast a través de la sección de Relaciones con Inversores en el sitio web de Madrigal Pharmaceuticals. Para asegurar una conexión a tiempo, se aconseja a los participantes registrarse al menos 15 minutos antes del inicio programado. El webcast permanecerá disponible durante aproximadamente dos horas después de que concluya el evento en vivo.
Madrigal Pharmaceuticals (Nasdaq: MDGL)는 2024년 3분기 재무 결과를 2024년 10월 31일 목요일, 미국 금융 시장 개장 전에 발표할 것이라고 발표했습니다. 이어 회사 경영진은 동부 표준시 기준 오전 8시에 Madrigal의 재무 및 운영 결과를 검토하는 실시간 웹캐스트를 개최할 것입니다.
관심 있는 분들은 Madrigal Pharmaceuticals 웹사이트의 투자자 관계 섹션을 통해 웹캐스트에 접속할 수 있습니다. 연결이 원활하게 이루어지도록 참여자는 예정된 시작 시간보다 최소 15분 전에 등록하는 것이 좋습니다. 웹캐스트는 라이브 이벤트가 종료된 후 약 2시간 동안 이용 가능합니다.
Madrigal Pharmaceuticals (Nasdaq: MDGL) a annoncé qu'il publierait ses résultats financiers du troisième trimestre 2024 le jeudi 31 octobre 2024, avant l'ouverture des marchés financiers américains. Par la suite, la direction de l'entreprise animera un webinaire en direct à 8 h, heure de l'Est pour examiner les résultats financiers et opérationnels de Madrigal.
Les parties intéressées peuvent accéder au webinaire via la section Relations avec les Investisseurs du site Web de Madrigal Pharmaceuticals. Pour garantir une connexion à l'heure, il est conseillé aux participants de s'inscrire au moins 15 minutes avant l'heure de début prévue. Le webinaire sera disponible pendant environ deux heures après la fin de l'événement en direct.
Madrigal Pharmaceuticals (Nasdaq: MDGL) hat angekündigt, dass die Finanzergebnisse für das dritte Quartal 2024 am Donnerstag, den 31. Oktober 2024, vor der Eröffnung der US-Finanzmärkte veröffentlicht werden. Anschließend wird das Management des Unternehmens ein Live-Webcast um 8 Uhr Eastern Time hosten, um die finanziellen und betrieblichen Ergebnisse von Madrigal zu überprüfen.
Interessierte Parteien können über den Bereich Investor Relations auf der Website von Madrigal Pharmaceuticals auf den Webcast zugreifen. Um eine rechtzeitige Verbindung zu gewährleisten, wird den Teilnehmern geraten, sich mindestens 15 Minuten vor dem geplanten Beginn anzumelden. Der Webcast wird ungefähr zwei Stunden nach dem Ende der Live-Veranstaltung verfügbar bleiben.
- None.
- None.
CONSHOHOCKEN, Pa., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) announced today that it will release its third-quarter 2024 financial results on Thursday, Oct. 31, 2024, prior to the open of the U.S. financial markets.
Following the announcement, Madrigal’s management will host a live webcast at 8 a.m. Eastern Time to review the Company’s financial and operating results.
The live webcast may be accessed at the Investor Relations section of the Madrigal Pharmaceuticals website. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast.
The webcast will be available approximately two hours after the live webcast.
About Madrigal Pharmaceuticals
Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH), a liver disease with high unmet medical need. Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of NASH. For more information, visit www.madrigalpharma.com.
Investor Contact
Tina Ventura, IR@madrigalpharma.com
Media Contact
Christopher Frates, media@madrigalpharma.com
FAQ
When will Madrigal Pharmaceuticals (MDGL) release its Q3 2024 financial results?
What time is Madrigal Pharmaceuticals' (MDGL) Q3 2024 earnings webcast?
How can I access Madrigal Pharmaceuticals' (MDGL) Q3 2024 earnings webcast?
How long will Madrigal Pharmaceuticals' (MDGL) Q3 2024 earnings webcast be available after the live event?
